Australia markets close in 39 minutes

BiomX Inc. (PHGE-UN)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.790.00 (0.00%)
At close: 2:24PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3150.73M
Trailing P/E N/A
Forward P/E 1-5.34
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)3.41
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-4.57

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 334.63%
52-week high 36.79
52-week low 36.51
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 16.1M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-30.14%
Return on equity (ttm)-55.22%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -32.98M
Net income avi to common (ttm)-33.72M
Diluted EPS (ttm)-1.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.27M
Total cash per share (mrq)1.64
Total debt (mrq)5.67M
Total debt/equity (mrq)11.67
Current ratio (mrq)6.42
Book value per share (mrq)1.99

Cash flow statement

Operating cash flow (ttm)-25.84M
Levered free cash flow (ttm)-16.15M